Burstable Health Team
Health In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
358 articles
Articles
Annovis Bio's Buntanetap Shows Promise in Halting Cognitive Decline in Parkinson's Patients with Alzheimer's Co-pathology
Annovis Bio Inc. released new findings from its Phase 3 early Parkinson's disease study demonstrating that buntanetap halted cognitive decline across all patients and delivered the strongest benefit in those with mild dementia and amyloid co-pathology. This subgroup represents approximately 25% of the study population and t...
November 17, 2025Read more
CNS Pharmaceuticals Reports Progress on Brain Cancer Drug TPI 287 in Third-Quarter Results
CNS Pharmaceuticals Inc. has reported third-quarter 2025 financial results while highlighting significant progress with its lead drug candidate TPI 287, a blood-brain barrier-permeable abeotaxane being developed for glioblastoma and other central nervous system tumors. The company's Phase 1 clinical data demonstrated potent...
November 17, 2025Read more
NRx Pharmaceuticals Reports Q3 2025 Progress in Suicidal Depression Treatments
NRx Pharmaceuticals, Inc. reported third-quarter 2025 results while highlighting substantial progress across its clinical pipeline, particularly for treatments targeting suicidal depression. The company noted its first revenue-generating activities alongside key regulatory advancements for both NRX-100 and NRX-101 programs....
November 17, 2025Read more
NanoViricides Reports Progress on Broad-Spectrum Antiviral NV-387 Amid Public Health Concerns
NanoViricides, Inc. has filed its Form 10-Q for the quarter ended September 30, 2025, detailing substantial progress on its lead drug candidate NV-387, a first-in-class broad-spectrum antiviral designed to resist viral escape by mimicking conserved sulfated proteoglycan receptors used by more than 90% of viruses. The compan...
November 17, 2025Read more
Keep A Breast Foundation Marks 25-Year Partnership Milestone with Vans Warped Tour
The Keep A Breast Foundation concluded its 25th anniversary celebrations during the final weekend of Vans Warped Tour in Orlando, marking a significant milestone for both organizations. KAB first joined the tour in 1998, creating a partnership that has spanned decades and transformed how breast health education reaches youn...
November 17, 2025Read more
Nursing Student Awarded Scholarship for Analysis of Healthcare Workforce Crisis
Schenk Nursing Home Abuse Law announced Justin Coffman as the recipient of the 2025 Fighting the Nursing Shortage Scholarship, a $2,000 award supporting nursing students at accredited U.S. institutions. The scholarship program encourages applicants to explore how the healthcare industry can become more accessible to incomin...
November 17, 2025Read more
Ergonomic Furniture Reaches Historic Low Prices During 2025 Black Friday Season
The 2025 Black Friday season has triggered a fundamental shift in the ergonomic furniture market, with premium office chairs and standing desks reaching their lowest price points ever recorded. Odinlake's month-long Mega Sale, running from November 1 to December 1, 2025, represents what industry analysts describe as a pivot...
November 16, 2025Read more
CNS Pharmaceuticals Advances Brain Cancer Treatment Targeting Blood-Brain Barrier Challenge
CNS Pharmaceuticals Inc. is intensifying its focus on glioblastoma multiforme, an aggressive brain cancer with limited treatment options that represents one of oncology's most significant unmet needs. CEO John Climaco emphasized the company's commitment to overcoming the blood-brain barrier, a major obstacle in brain cancer...
November 14, 2025Read more
HeartBeam Advances Toward FDA Clearance for Breakthrough 3D Cardiac Monitoring Technology
HeartBeam Inc. reported third-quarter 2025 financial results while highlighting significant progress toward commercialization of its 12-lead ECG synthesis software, now in the final stage of FDA 510(k) review with anticipated clearance expected by year end. The company's technology represents a potential breakthrough in car...
November 14, 2025Read more
GLP-1 Medications Show 50% Lower Mortality in Colon Cancer Patients, UC San Diego Study Finds
Colon cancer patients using GLP-1 medications such as Ozempic and Wegovy demonstrated a 50% lower mortality rate compared to those not taking these drugs, according to recent research from UC San Diego. The findings suggest that medications already approved for specific clinical indications may have additional therapeutic b...
November 14, 2025Read more
Peptides Emerge as Versatile Biochemical Modulators with Broad Therapeutic Implications
Peptides, consisting of short chains of amino acids linked by peptide bonds, serve as essential biochemical modulators with significant implications for therapeutic research and experimental design. These molecules function as either signaling or structural entities, with their sequence, structure, and chemical characterist...
November 14, 2025Read more
Wellness Eternal's Biohacking Index Report Highlights Top Brands Driving Industry Transparency
Wellness Eternal has released the October 2025 Biohacking Index Report, developed in collaboration with Robin Switzer, Founder and CEO of Q1 Productions and Creator of Hack Your Health. The report identifies ten high-growth wellness and longevity brands that are achieving measurable outcomes through practitioner engagement,...
November 13, 2025Read more
Former NASA Engineer Releases Book on Energy Therapy for Anxiety Management
"Go Find Joy: The Science of Calm" Introduces PEMF Technology as Drug-Free Alternative for Anxiety Management
November 13, 2025Read more
Rooted Wellness Retreats Launches Exclusive Functional Medicine Program in Hawaii for 2026
Rooted Wellness Retreats opens applications for its 6-day functional medicine immersion in Kona, Hawaii, February 26–March 3, 2026. Designed for just 12 participants, the retreat offers personalized care, nourishing meals, and real transformation — body, mind, and spirit.
November 13, 2025Read more
Strawberry Fields REIT Expands Portfolio to Capture Growing Elderly Care Market
Strawberry Fields REIT Inc. is positioning itself to capture significant market share in the expanding elderly care sector through an aggressive expansion strategy. The self-administered real estate investment trust currently owns and holds long-term leasehold interests in 142 healthcare facilities spanning ten states, repr...
November 13, 2025Read more
HeartBeam and HeartNexus Partnership Expands Remote Cardiac Monitoring with 24/7 Cardiologist Access
HeartBeam Inc. has announced a strategic collaboration with HeartNexus that will expand access to cardiologist-level ECG insights for arrhythmia assessment. The partnership makes board-certified cardiologists available 24/7 to interpret results from HeartBeam's portable ECG system and provide expert feedback directly to pat...
November 13, 2025Read more
NextPlat Corp Reports Third-Quarter 2025 Financial Results with Revenue Decline but Improved Cost Management
NextPlat Corp reported third-quarter 2025 financial results showing consolidated revenue of approximately $13.8 million compared to $15.4 million in the prior year period. The revenue decline primarily reflected lower 340B pharmacy contract revenue, though the company noted that late-quarter customer re-engagement efforts d...
November 13, 2025Read more
SOBRsafe Reports 136% Revenue Growth in Q3 2025 Driven by Alcohol Detection Technology Adoption
SOBRsafe Inc. reported significant financial momentum in the third quarter of 2025, with revenue increasing 136.1 percent year over year, driven primarily by accelerating adoption of the company's SOBRsure GEN 2 alcohol detection device. The technology accounted for more than 80 percent of quarterly revenue, demonstrating s...
November 13, 2025Read more
BRYGE AI Wins Silver Stevie Award for ADHD Communication Assistant
BRYGE AI, an ADHD communication assistant designed to help neurotypicals communicate more clearly and compassionately with people who have ADHD, has been awarded the Silver Stevie Award for Best Health Tech Product for Women at the 2025 Stevie Awards for Women in Business. The tool, developed by Rebecca Koniahgari, uses art...
November 13, 2025Read more
HeartBeam Recognized as Global Leader in Portable Cardiac Diagnostics Technology
HeartBeam has been recognized as a Global IP and Technology Leader in Portable Cardiac Diagnostics by PatentVest's "Total Cardiac Intelligence" report. The medical-technology company ranked second worldwide in 12-lead ECG innovation among 243 firms analyzed, trailing only GE Healthcare in the comprehensive evaluation availa...
November 12, 2025Read more
Strawberry Fields REIT Reports Strong Q3 2025 Growth Through Strategic Healthcare Acquisitions
Strawberry Fields REIT Inc. reported substantial financial growth for the third quarter of 2025, driven by strategic acquisitions of healthcare facilities across multiple states. The self-administered Real Estate Investment Trust specializing in healthcare-related properties announced results for the quarter ending Septembe...
November 12, 2025Read more